Is Cold Chain Really A Challenge Facing mRNA Therapeutics?

Many critical raw materials for mRNA production require strict storage and handling conditions to preserve their quality. mRNA products often require storage at extremely low temperatures, which is challenging to maintain throughout storage and transportation. Here, Joseph Barberio, VP Technical Operations at Strand Therapeutics and Christian Moreno, Director of Supply Chain Management at Nutcracker Therapeutics share their take on existing cold chain challenges.